Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 2999

BillFederalHouseIn Committee
Patients' Access to Treatments Act of 2017
About This Bill
Committee
Latest Action · June 23, 2017
Referred to the Subcommittee on Health.
Congress
115th (2017–2019)
Introduced
June 22, 2017
Cosponsors (35)
27D 8R
View PDF ↗

Summary

Highlight any text to annotate
Patients' Access to Treatments Act of 2017 This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.